Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Exenatide for Myocardial Protection During Reperfusion Study (EMPRES)

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2014 by University Health Network, Toronto
Bristol-Myers Squibb
Information provided by (Responsible Party):
Vlad Dzavik, University Health Network, Toronto Identifier:
First received: August 29, 2013
Last updated: February 5, 2014
Last verified: February 2014
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2015
  Estimated Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)